返回 Agenda
Session 2 - The Dynamics of Decentralised Clinical Trials
Session Chair(s)
Audrey Ooi, MSc
Head- Business Development
Clinical Research Malaysia, Malaysia
Vicky Hsu
Senior Vice President, Head of Project Leadership and Biotech Operations Asia
Parexel International, Singapore
The advent of the Covid-19 pandemic has accelerated the interest and adoption of decentralized clinical trials (DCT). While this has the potential to generate new innovations and improve the patient experience, how can we ensure decentralized trials continue to benefit patients, clinicians, trial sites and sponsors beyond the pandemic setting? In this session, we will learn about the adoption of DCTs, the challenges faced and what the future holds for DCT in this region.
Speaker(s)
The Future of Decentralize Clinical Trials in Asia
Jerome Armellini
IQVIA, Singapore
Asia Head - Clinical Development & Operations Strategy R&D Solutions Asia
Successful Remote Monitoring Implementation Strategy
Serena Chan
Syneos Health Singapore Pte Ltd., Singapore
General Manager SEA & APAC Chief of Staff Clinical Development
Trends And Acceptance Of Decentralize Clinical Trial Practices in Asia/APAC
Daniela Caiazza
Novotech CRO, Australia
Senior Director Clinical Services And Innovations
Trends And Acceptance Of Decentralize Clinical Trial Practices in Asia/APAC
Neil Smith
ObvioHealth , Australia
Director of Clinical Operations